Phthalic Acid

Phthalic Acid

SCHEMBL382866

Cl.O=C(O)c1ccccc1C(=O)O

nearest known ligand 0.93

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO

The experimentally established mechanism targets of Phthalic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA2 known ✓ P00918 1/20 0.65
HDAC8 known ✓ Q9BY41 1/20 0.62
ALDH1A1 P00352 4/20 0.93
ALOX15 P16050 1/20 0.93
AKR1C3 P42330 3/20 0.67
NAPRT Q6XQN6 2/20 0.65
KDM4E B2RXH2 1/20 0.65
CA12 O43570 1/20 0.65
CA1 P00915 1/20 0.65
HMGB1 P09429 1/20 0.65
HPGD P15428 1/20 0.65
CA4 P22748 1/20 0.65
CA6 P23280 1/20 0.65
CA7 P43166 1/20 0.65
SMN1; SMN2 Q16637 1/20 0.65
CA9 Q16790 1/20 0.65
CA14 Q9ULX7 1/20 0.65
MAPT P10636 2/20 0.62
POLB P06746 1/20 0.59
NR4A1 P22736 3/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phthalic Acid SCHEMBL22453 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL5036784 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL29396592 1.00 ALDH1A1 (0.93) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL29037475 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL10891138 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL29037477 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL28656910 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL28625830 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL4585517 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E
Phthalic Acid SCHEMBL28286107 0.97 ALDH1A1 (0.88) ALDH1A1ALOX15AKR1C3NAPRTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 864 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4722284-A1 LOW MELTING CARBOXAMIDE HALS FOR IMPROVED STABILIZATION OF POLYMERS OR RESINS CLARIANT INTERNATIONAL LTD (CH) 2026-04-08 EP claimed
CN-118685634-A Separation and recovery method for lithium ions in retired waste lithium batteries based on nanofiltration-reverse osmosis method 广东奥斯博膜材料技术有限公司 2024-09-24 CN claimed
CN-118236346-A Lung-targeted ionizable lipid nanoparticle, and preparation method and application thereof 北京科技大学 2024-06-25 CN claimed
CN-118183749-A Nano silicon @ SiOx/MXene composite anode material and preparation method thereof 昆明理工大学 2024-06-14 CN claimed
US-20240180832-A1 COMPOUND, LIPOSOME, AND USES THEREOF BEIJING INSTITUTE OF TECHNOLOGY (CN) 2024-06-06 US claimed
CN-118063794-A Preparation method of lignin containing primary amine groups 新疆农业大学 2024-05-24 CN claimed
CN-117959942-A Preparation method of high-flux stain-resistant composite membrane 浙江理工大学 2024-05-03 CN claimed
CN-117903879-A Cleaning solution for removing residues after etching of copper process aluminum pad 湖北兴福电子材料股份有限公司 2024-04-19 CN claimed
CN-117886685-A 1, 3-diaryl formyl benzene compound and preparation method and application thereof 浙江工业大学 2024-04-16 CN claimed
EP-4342881-A1 COMPOUND, LIPOSOME, AND USES THEREOF Beijing Institute Of Technology (CN) 2024-03-27 EP claimed
CN-1800229-A Preparation of monodispersion high molecular nanometer sphere using envelop virus as template UNIV TIANJIN TECHNOLOGY (CN) 2006-07-12 CN claimed
EP-1341830-B1 METHOD FOR PRODUCING THERMOPLASTIC MOLDING MATERIALS CONTAINING RUBBER BASF AG (DE) 2006-01-11 EP claimed
US-20050041569-A1 Optical disk LG ELECTRONICS INC. 2005-02-24 US claimed
US-20040102564-A1 Method for producing thermoplastic molding materials containing rubber BASF AKTIENGESELLSCHAFT (DE) 2004-05-27 US claimed
EP-1045291-A2 Method of improving the etch resistance of photoresists Infineon Technologies North America Corp. (US) 2000-10-18 EP claimed
CN-1264061-A Method for improving photoetching rubber elching resistant YINFENNIAN TECHNOLOGY NORTH AM (US) 2000-08-23 CN claimed
EP-0611326-B1 METHOD FOR PRODUCING NANOCAPSULES WITH CROSS-LINKED PROTEIN-BASED WALLS, NANOCAPSULES THEREBY OBTAINED, AND COSMETIC, PHARMACEUTICAL AND FOOD COMPOSITIONS USING SAME COLETICA (FR) 1997-08-06 EP claimed
EP-0513252-A1 HIGH PURITY AROMATIC POLYESTER, A FILM AND OTHER PRODUCTS AND DEVICES CONTAINING SUCH POLYESTER AS WELL AS A PROCESS FOR PREPARING SUCH FILM ISONOVA TECHNISCHE INNOVATIONEN GES.M.B.H. (AT) 1992-11-19 EP claimed
WO-1992003493-A1 HIGH PURITY AROMATIC POLYESTER, A FILM AND OTHER PRODUCTS AND DEVICES CONTAINING SUCH POLYESTER AS WELL AS A PROCESS FOR PREPARING SUCH FILM ISONOVA TECHNISCHE INNOVATIONEN GESELLSCHAFT M.B.H. (AT) 1992-03-05 WO claimed
US-4868265-A Polyanhydride process from bis(trimethylsilyl) ester of dicarboxylic acid HOECHST CELANESE CORP. (US) 1989-09-19 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240180832-A1 COMPOUND, LIPOSOME, AND USES THEREOF LIPA, LIPC, PNLIP CA2 4841/4885HDAC8 2423/4885ALDH1A1 3790/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.